BofA Global Research cuts Pershing Square price objective to $38 from $54
PS•BofA Global Research cut its price objective for Pershing Square Inc to $38 from $54.
Related News
Tilray Medical wins INFARMED approval for in-house EU-GMP quality testing at Portugal facility
TLRY•
SS&C GlobeOp Capital Movement Index shows hedge fund net flows fall 0.16% in October
SSNC•
Freshpet: TD Cowen cuts target price to $80 from $85
FRPT•
FIS: Goldman Sachs cuts target price to $44 from $52
FIS•
Goosehead Insurance target price cut to $48 from $58 by Truist Securities
GSHD•